Pearl Women'S Hospital And Yash - Ivf India Profile
Key Indicators
- Authorised Capital ₹ 3.29 Cr
as on 17-12-2024
- Paid Up Capital ₹ 3.22 Cr
as on 17-12-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.57 Cr
as on 17-12-2024
- Satisfied Charges ₹ 0.31 M
as on 17-12-2024
- Revenue 5.25%
(FY 2023)
- Profit 3.83%
(FY 2023)
- Ebitda 3.09%
(FY 2023)
- Net Worth 31.38%
(FY 2023)
- Total Assets 13.20%
(FY 2023)
About Pearl Women'S Hospital And Yash - Ivf India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.29 Cr and a paid-up capital of Rs 3.22 Cr.
The company currently has active open charges totaling ₹26.57 Cr. The company has closed loans amounting to ₹0.31 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Kulkarni and Chaitanya Ganapule serve as directors at the Company.
- CIN/LLPIN
U85191PN2014PTC152601
- Company No.
152601
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pearl Women'S Hospital And Yash - Ivf India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chaitanya Ganapule  | Managing Director | 19-Sep-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Kulkarni | Director | 04-Jul-2023 | Current |
Financial Performance of Pearl Women'S Hospital And Yash - Ivf India.
Pearl Women'S Hospital And Yash - Ivf India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.25% increase. The company also saw a slight improvement in profitability, with a 3.83% increase in profit. The company's net worth Soared by an impressive increase of 31.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pearl Women'S Hospital And Yash - Ivf India?
In 2023, Pearl Women'S Hospital And Yash - Ivf India had a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
G-2 Sante Soin LlpActive 10 years 11 monthsRavindra Kulkarni and Chaitanya Ganapule are mutual person
- Be Well Pharmacy LlpActive 5 years 10 days
Ravindra Kulkarni and Chaitanya Ganapule are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jan 2024 | ₹4.95 M | Open |
Others Creation Date: 03 Nov 2023 | ₹25.06 Cr | Open |
Others Creation Date: 21 Mar 2020 | ₹4.69 M | Open |
How Many Employees Work at Pearl Women'S Hospital And Yash - Ivf India?
Unlock and access historical data on people associated with Pearl Women'S Hospital And Yash - Ivf India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pearl Women'S Hospital And Yash - Ivf India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pearl Women'S Hospital And Yash - Ivf India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
